The Asia-Pacific electrophysiology (EP) market, consisting of ablation catheters, diagnostic catheters and lab systems.
The growth of the Asia- Pacific Electrophysiology market is driven by several factors, the most important of which is the technological innovations. Technological innovations and advancements have led to the introduction of new products . The other factors promoting the growth of the market are increasing incidences of chronic diseases, , ease of use and interpretation of medical devices. Factors constraining the growth of the market include reimbursement issues, high cost of the medical devices .Emerging economies, Public awareness for cardiac disease are the major opportunities in the market.
The report segments the market by types( Electrophysiology monitoring devices, Treatment devices) and based on geography(India, China, Japan)Asia-Pacific shows very potential market due to increasing technological innovations, and increasing per capita income and growing economy.
Major companies discussed in this report with their profile and relevant information from market perspective are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific, GE Healthcare, Johnson & Johnson, Medtronic Inc., Microport
What makes our report unique??
1) An extensive research study on the Electrophysiology market, and its entire ecosystem, describes the market trends, drivers, restraints and opportunities of the wearable electronics.
2) We provide the longest segmentation of the market based on products, technology, components, form factor, products application, industry verticals, and geography.
3) This report gives a birds eye-view of the market competitive landscape which includes mergers & acquisitions, collaborations., new product launches and key players in the market.
1.1 Report description
1.2 Research methodology
2. Executive summary
3. MARKET OVERVIEW
3.2 MARKET SIZE AND FORECASTS
3.3 MARKET DYNAMICS
3.3.1 MARKET DRIVERS
220.127.116.11 RAPIDLY INCREASING AGED POPULTAION
18.104.22.168 INCREASING CASES OF CARDIAC DISEASES
22.214.171.124 TECHNOLOGICAL ADVANCEMENTS
3.3.2 MARKET RESTRAINTS
126.96.36.199 HIGH COST OF TREATMENT
188.8.131.52 REGULATORY ISSUES
184.108.40.206 PATIENT PROTECTION AND AFFORDABLE CARE ACT
220.127.116.11 INCREASING HEALTHCARE EXPENDITURE
18.104.22.168 RISING ADOPTION OF ABLATION TECHNIQUES
22.214.171.124 EMERGING ECONOMIES
126.96.36.199 PUBLIC AWARENESS FOR CARDIAC DISEASES
188.8.131.52 HUGE SCOPE FOR CONSOLIDATION
3.3.4 PORTER'S FIVE FORCE ANALYSIS
184.108.40.206 BARGAINING POWER OF SUPPLIERS
220.127.116.11 BARGAINING POWER OF BUYERS
18.104.22.168 THREAT OF SUBSTITUTES
22.214.171.124 THREAT FROM NEW ENTRANT
126.96.36.199 COMPETITIVE RIVALRY
4. Market segmentation
4.1 Market segmentation,by type of products
4.1.1 Electrophysiology monitoring devices
188.8.131.52 Electrocardiograph (ECG)
184.108.40.206 Electroencephalograph (EEG)
220.127.116.11 Electrocorticograph (ECOG)
18.104.22.168 Electromyograph (EMG)
22.214.171.124 Electroretinograph (ERG)
126.96.36.199 Electrooculograph (EOG)
188.8.131.52 Holter monitoring devices
184.108.40.206 X-ray systems
220.127.116.11 Imaging and 3d mapping systems
18.104.22.168 Diagnostic electrophysiology catheters
4.1.2 Electrophysiology treatment devices
22.214.171.124 Implantable cardioverter defibrillators (ICDS)
126.96.36.199 Cardiac resynchronization therapy devices (CRTS)
188.8.131.52.1 Radiofrequency electrophysiology ablation catheters
184.108.40.206.2 Cryoablation electrophysiology catheters
220.127.116.11.3 Laser ablation catheters
18.104.22.168.4 Microwave ablation catheters
4.2 Electrophysiology treatment devices, by geography
5. Competitive Landscape
5.3 Product launches/developments
6. COMPANY PROFILES
6.1 Biosense webster, inc.
6.2 St. Jude medical, inc.
6.3 Japan lifeline co., ltd.
6.4 Biotronik se & co. Kg
6.5 Boston scientific corporation
6.6 Medtronic, inc.
6.7 C. R. Bard, inc.